| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/16/2022 | Celldex Therapeutics, Inc. | CLDX | Grant | | 13.6k | $22.48 | $305.7k | | 06/16/2022 |
| 06/17/2021 | Celldex Therapeutics, Inc. | CLDX | Grant | | 12k | $28.00 | $336k | | 06/17/2021 |
| 06/18/2020 | Celldex Therapeutics, Inc. | CLDX | Grant | | 11k | $10.38 | $114.2k | | 06/18/2020 |
| 06/19/2019 | Celldex Therapeutics, Inc. | CLDX | Grant | | 4.5k | $2.78 | $12.5k | | 06/19/2019 |
| 02/13/2019 | Phio Pharmaceuticals Corp. | RXII | Grant | Common stock | 10k | $0.00 | $0 | | 02/13/2019 |
| 09/27/2018 | SOLIGENIX, INC. | SNGX | Grant | | 18k | $1.67 | $30k | | 09/27/2018 |
| 08/01/2018 | Phio Pharmaceuticals Corp. | RXII | Grant | Common Stock | 10k | $0.00 | $0 | | 08/01/2018 |
| 06/13/2018 | Celldex Therapeutics, Inc. | CLDX | Grant | | 67k | $0.60 | $40.3k | | 06/13/2018 |
| 06/08/2017 | SOLIGENIX, INC. | SNGX | Grant | | 13.1k | $2.29 | $30k | | 06/08/2017 |
| 02/01/2017 | Phio Pharmaceuticals Corp. | RXII | Grant | Stock option (right to buy) | 2k | $0.63 | $1.3k | | 02/01/2017 |
| 02/10/2016 | Phio Pharmaceuticals Corp. | RXII | Grant | Stock option (right to buy) | 16.7k | $0.29 | $4.8k | | 02/10/2016 |
| 06/18/2015 | SOLIGENIX, INC. | SNGX | Grant | | 19.9k | $1.51 | $30k | | 06/18/2015 |
| 06/01/2015 | Phio Pharmaceuticals Corp. | RXII | Grant | Stock option (right to buy) | 16.7k | $0.38 | $6.3k | | 06/01/2015 |
| 04/09/2015 | SOLIGENIX, INC. | SNGX | Exercise | Common Stock Warrant | 14.3k | $0.61 | $8.7k | | 04/09/2015 |
| 06/19/2014 | SOLIGENIX, INC. | SNGX | Grant | | 13.7k | $2.19 | $29.9k | | 06/19/2014 |
| 06/02/2014 | Phio Pharmaceuticals Corp. | RXII | Grant | Stock Option (right to buy) | 16.7k | $2.85 | $47.5k | | 06/02/2014 |
| 05/22/2014 | Vyant Bio, Inc. | CGIX | Grant | Common Stock, par value $0.0001 per share | 5k | $0.00 | $0 | | 05/22/2014 |
| 05/22/2014 | Vyant Bio, Inc. | CGIX | Grant | Stock Option (right to buy) | 10k | $11.70 | $117k | | 05/22/2014 |
| 05/14/2014 | SOLIGENIX, INC. | SNGX | Exercise | Option (Right to Buy) | 16.7k | $0.30 | $5k | | 05/14/2014 |
| 06/07/2013 | Phio Pharmaceuticals Corp. | RXII | Grant | Stock Option (right to buy) | 500k | $0.20 | $100k | | 06/07/2013 |
| 06/22/2011 | SOLIGENIX, INC. | SNGX | Grant | | 300k | $0.20 | $59.7k | | 06/22/2011 |